Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybutynin for Hot Flashes in Men on ADT
NCT04600336Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Oct 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxybutynin in hot flashes, sponsored by Cancer and Leukemia Group B. Started Oct 2021; status: completed.
02
Drugs
oxybutynin
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT04600336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04600336.